ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

J90 NurExone Biologic Inc

0.334
0.002 (0.60%)
24 May 2024 - Cerrado
Datos en tiempo real
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
NurExone Biologic Inc J90 Tradegate Acción Ordinaria
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.002 0.60% 0.334 16:50:01
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
0.33 0.306 0.332 0.334 0.332
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
17/5/202415:04GLOBENurExone Welcomes Biopharma Exec Dr. Ram Petter to Drive..
25/4/202407:35GLOBENurExone Biologic Inc. Announces Strategic Expansion to US..
19/4/202415:04GLOBENurExone Presenting on Revolutionary Spinal Cord Injury..
02/4/202407:31GLOBENurExone Reports Fourth Quarter and Year Ended December 31,..
27/3/202416:05GLOBEGross Proceeds Close of $4M CAD Generated for NurExone From..
22/3/202416:04GLOBEIn Preparation for Expected Human Clinical Trials, NurExone..
15/3/202415:05GLOBENurExone's Strategic Update: Submission of OTCQB Listing..
08/3/202415:05GLOBENurExone establishing State-of-the-Art Research and..
01/3/202415:04GLOBENurExone Presenting Novel Regulatory Pathways for Exosomes..
20/2/202415:05GLOBENurExone’s Intellectual Property Portfolio Expands
14/2/202415:20GLOBENurExone Launches Licensing Efforts for ExoTherapy Platform
02/2/202415:05GLOBENurexone Biologic Initiates European Orphan Drug Designation..
17/1/202407:34GLOBENurExone and Inteligex Kick Off Chronic Spinal Cord Injury..
05/1/202407:30GLOBENurExone Announces Closing of a Private Placement for Gross..
29/11/202307:30GLOBENurExone Biologic Extends Spinal Cord Injury Therapy..
24/11/202307:30GLOBENurExone Reports Third Quarter 2023 Financial Results and..
30/10/202308:20GLOBENurExone Biologic Receives FDA Orphan-Drug Designation,..
19/10/202307:30GLOBEAppointment of Professor Teo Forcht Dagi to Scientific..
11/10/202307:30GLOBENurExone Secures Eureka Grant for Collaborative..
05/10/202307:30GLOBENurExone Biologic to Present Exosome-Based Therapy for..
28/9/202307:30GLOBENurExone Appoints Dr. Reuter Investor Relations in Europe
13/9/202307:30GLOBENurExone Moves Forward Towards Human Clinical Trials,..
06/9/202307:30GLOBENurExone Announces Closing of Second Tranche of Private..